BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 31971984)

  • 1. The cervicovaginal mucus barrier to HIV-1 is diminished in bacterial vaginosis.
    Hoang T; Toler E; DeLong K; Mafunda NA; Bloom SM; Zierden HC; Moench TR; Coleman JS; Hanes J; Kwon DS; Lai SK; Cone RA; Ensign LM
    PLoS Pathog; 2020 Jan; 16(1):e1008236. PubMed ID: 31971984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced Trapping of HIV-1 by Human Cervicovaginal Mucus Is Associated with Lactobacillus crispatus-Dominant Microbiota.
    Nunn KL; Wang YY; Harit D; Humphrys MS; Ma B; Cone R; Ravel J; Lai SK
    mBio; 2015 Oct; 6(5):e01084-15. PubMed ID: 26443453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive functional analysis reveals inferred features unique to cervicovaginal microbiota of African women with bacterial vaginosis and high-risk human papillomavirus infection.
    Onywera H; Anejo-Okopi J; Mwapagha LM; Okendo J; Williamson AL
    PLoS One; 2021; 16(6):e0253218. PubMed ID: 34143825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Cervicovaginal Microbiota and Its Associations With Human Papillomavirus Detection in HIV-Infected and HIV-Uninfected Women.
    Reimers LL; Mehta SD; Massad LS; Burk RD; Xie X; Ravel J; Cohen MH; Palefsky JM; Weber KM; Xue X; Anastos K; Minkoff H; Atrio J; D'Souza G; Ye Q; Colie C; Zolnik CP; Spear GT; Strickler HD
    J Infect Dis; 2016 Nov; 214(9):1361-1369. PubMed ID: 27521363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Standard Bacterial Vaginosis Treatment on the Genital Microbiota, Immune Milieu, and Ex Vivo Human Immunodeficiency Virus Susceptibility.
    Joag V; Obila O; Gajer P; Scott MC; Dizzell S; Humphrys M; Shahabi K; Huibner S; Shannon B; Tharao W; Mureithi M; Oyugi J; Kimani J; Kaushic C; Ravel J; Anzala O; Kaul R
    Clin Infect Dis; 2019 May; 68(10):1675-1683. PubMed ID: 30407498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaginal microbiota of asymptomatic bacterial vaginosis and vulvovaginal candidiasis: Are they different from normal microbiota?
    Pramanick R; Mayadeo N; Warke H; Begum S; Aich P; Aranha C
    Microb Pathog; 2019 Sep; 134():103599. PubMed ID: 31212037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deep sequencing of the vaginal microbiota of women with HIV.
    Hummelen R; Fernandes AD; Macklaim JM; Dickson RJ; Changalucha J; Gloor GB; Reid G
    PLoS One; 2010 Aug; 5(8):e12078. PubMed ID: 20711427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular assessment of bacterial vaginosis by Lactobacillus abundance and species diversity.
    Dols JA; Molenaar D; van der Helm JJ; Caspers MP; de Kat Angelino-Bart A; Schuren FH; Speksnijder AG; Westerhoff HV; Richardus JH; Boon ME; Reid G; de Vries HJ; Kort R
    BMC Infect Dis; 2016 Apr; 16():180. PubMed ID: 27107961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Female genital-tract HIV load correlates inversely with Lactobacillus species but positively with bacterial vaginosis and Mycoplasma hominis.
    Sha BE; Zariffard MR; Wang QJ; Chen HY; Bremer J; Cohen MH; Spear GT
    J Infect Dis; 2005 Jan; 191(1):25-32. PubMed ID: 15592999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diversity of cervicovaginal microbiota associated with female lower genital tract infections.
    Ling Z; Liu X; Chen X; Zhu H; Nelson KE; Xia Y; Li L; Xiang C
    Microb Ecol; 2011 Apr; 61(3):704-14. PubMed ID: 21287345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-Sectional Analysis of Selected Genital Tract Immunological Markers and Molecular Vaginal Microbiota in Sub-Saharan African Women, with Relevance to HIV Risk and Prevention.
    Kyongo JK; Crucitti T; Menten J; Hardy L; Cools P; Michiels J; Delany-Moretlwe S; Mwaura M; Ndayisaba G; Joseph S; Fichorova R; van de Wijgert J; Vanham G; Ariën KK; Jespers V
    Clin Vaccine Immunol; 2015 May; 22(5):526-38. PubMed ID: 25761460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Cervicovaginal Microbiota in Women Notified for Chlamydia trachomatis Infection: A Case-Control Study at the Sexually Transmitted Infection Outpatient Clinic in Amsterdam, The Netherlands.
    van der Veer C; Bruisten SM; van der Helm JJ; de Vries HJ; van Houdt R
    Clin Infect Dis; 2017 Jan; 64(1):24-31. PubMed ID: 27567124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of biofilms in bacterial vaginosis by an amphoteric tenside pessary-clinical study and microbiota analysis.
    Gottschick C; Deng ZL; Vital M; Masur C; Abels C; Pieper DH; Rohde M; Mendling W; Wagner-Döbler I
    Microbiome; 2017 Sep; 5(1):119. PubMed ID: 28903767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beyond bacterial vaginosis: vaginal lactobacilli and HIV risk.
    Armstrong E; Kaul R
    Microbiome; 2021 Dec; 9(1):239. PubMed ID: 34893070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the diversity of the vaginal microbiota in HIV-infected and HIV-uninfected women with or without bacterial vaginosis.
    Spear GT; Sikaroodi M; Zariffard MR; Landay AL; French AL; Gillevet PM
    J Infect Dis; 2008 Oct; 198(8):1131-40. PubMed ID: 18717638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defining characteristics of genital health in South African adolescent girls and young women at high risk for HIV infection.
    Dabee S; Barnabas SL; Lennard KS; Jaumdally SZ; Gamieldien H; Balle C; Happel AU; Murugan BD; Williamson AL; Mkhize N; Dietrich J; Lewis DA; Chiodi F; Hope TJ; Shattock R; Gray G; Bekker LG; Jaspan HB; Passmore JS
    PLoS One; 2019; 14(4):e0213975. PubMed ID: 30947260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human immunodeficiency virus type 1 is trapped by acidic but not by neutralized human cervicovaginal mucus.
    Lai SK; Hida K; Shukair S; Wang YY; Figueiredo A; Cone R; Hope TJ; Hanes J
    J Virol; 2009 Nov; 83(21):11196-200. PubMed ID: 19692470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The significance of Lactobacillus crispatus and L. vaginalis for vaginal health and the negative effect of recent sex: a cross-sectional descriptive study across groups of African women.
    Jespers V; van de Wijgert J; Cools P; Verhelst R; Verstraelen H; Delany-Moretlwe S; Mwaura M; Ndayisaba GF; Mandaliya K; Menten J; Hardy L; Crucitti T;
    BMC Infect Dis; 2015 Mar; 15():115. PubMed ID: 25879811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lactobacillus-dominated cervicovaginal microbiota associated with reduced HIV/STI prevalence and genital HIV viral load in African women.
    Borgdorff H; Tsivtsivadze E; Verhelst R; Marzorati M; Jurriaans S; Ndayisaba GF; Schuren FH; van de Wijgert JH
    ISME J; 2014 Sep; 8(9):1781-93. PubMed ID: 24599071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV inhibition by lactobacilli: easier in a test tube than in real life.
    Witkin SS; Linhares IM
    mBio; 2015 Oct; 6(5):e01485-15. PubMed ID: 26443461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.